Speakers

Elizabeth Tarshish

Elizabeth Tarshish

Head of Clinical Affairs, Lycored (Israel)

Global clinical development strategy and execution executive with over 15 years of experience.

Brings a strong background in clinical development and business operations with progressively responsible positions.  

An expert in multi-center global clinical studies management with wide experience in new drug development and global product development through all clinical phases in varies therapeutic indications.

Driven and adaptable manager with demonstrated career progression and experience including line management. Proven record as effective and esteemed team leader of global clinical operations and cross-functional teams.

Strong organizational, problem solving skills, effective management of project risks and process change.

Excellent communicator across all levels, good interpersonal skills, able to collaborate and drive the decision-making process.

In depth knowledge of ICH/GCP and clinical research regulation in multiple countries across regions.

 

Accountable for the development of the operational plans for clinical deliverables and effectively implement\ design excellence in line with the clinical development plans.

Responsible for the design of the clinical trials including the evaluation and implementation of novel clinical study designs.

 

Accountable for the performance and results of a large team of professionals.

Responsible for leading outsourcing strategies and coordinating global outsourcing processes including supplier identification, evaluation, selection, negotiation and management for clinical studies phase I-IV in various indications. Continuous evaluation of strategic outsourcing opportunities. Develop purchasing strategies and implement various outsourcing models.

Develop and lead innovative clinical studies and support the realization of clinical plans to ensure their quality and effectiveness.

 

Leading overall clinical development plans, target product profiles and the regulatory strategy.